ArticleFrontiers in public health2026
Association between different metabolic obesity phenotypes and hyperuricemia: the modifying role of liver enzymes.
Article in Frontiers in public health, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Association between the Zhejiang University index and hyperuricemia among adults with type 2 diabetes in China.Frontiers in endocrinology · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Hyperuricemia (HUA) is a rapidly increasing metabolic disorder that is closely linked to obesity, nonalcoholic fatty liver disease and cardiometabolic diseases. However, the relationships between different metabolic obesity phenotypes and HUA, and the potential modifying role of liver enzymes, remain unclear, particularly in occupational populations. Methods: In this cross-sectional study, we enrolled 1,867 Chinese oilfield workers undergoing routine occupational health examinations. Logistic regression models were used to estimate odds ratios (ORs) and 95% confidence intervals (CIs) for HUA. Generalized additive models with penalized smoothing splines were applied to explore potential non-linear associations of BMI and WC with HUA. Stratified analyses were conducted according to liver enzyme status. Results: The prevalence of HUA was 30.0% among oilfield workers. Both GO and AO were significantly associated with higher odds of HUA after multivariable adjustment (adjusted OR for GO: 1.83, 95% CI: 1.35-2.49; for AO: 1.38, 95% CI: 1.03-1.84). Compared with metabolically healthy non-obesity phenotypes, metabolically unhealthy obesity phenotypes showed the strongest associations with HUA, particularly MUGO (adjusted OR: 4.00, 95% CI: 2.69-6.06) and MUAO (adjusted OR: 3.73, 95% CI: 2.53-5.59). Generalized additive models revealed a linear positive relationship between BMI and HUA risk, whereas the association between WC and HUA was non-linear. Stronger associations between MUGO/MUAO and HUA were observed among individuals with elevated liver enzyme levels. Conclusion: In this population of oilfield workers, metabolically unhealthy obesity phenotypes, especially MUGO and MUAO, are strongly associated with HUA, with liver enzyme abnormalities acting as potential effect modifiers rather than causal determinants. Metabolic status and liver function appear to be important modifiers of obesity-related HUA risk. Integrating adiposity measures, metabolic components and liver enzyme indices may improve risk stratification and inform targeted prevention strategies for HUA in occupational settings.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.